Free company profile — no paywall, no login
Diffusion Pharmaceuticals Inc.
Charlottesville, Yhdysvallat
Diffusion Pharmaceuticals Inc., Charlottesville, Yhdysvallat · LEI: 549300I3DV7F8OXPNA12 · Yritysmuoto: Inc. · Tila: active. Revenue, earnings and total assets included. · Free company profile — no paywall, no login
−27 Mio. $
Corporate purpose
Als biopharmazeutisches Unternehmen konzentriert sich Diffusion Pharmaceuticals Inc. auf die Entwicklung neuartiger Behandlungen, die die Effizienz des Körpers bei der Sauerstoffverteilung verbessern. Die führende Prüftherapie des Unternehmens ist Trans-Natrium-Crocetinat, das entwickelt wurde, um die Sauerstoffausbreitung in Gewebe zu erleichtern. Diese Verbindung wird zudem für ihre Anwendung bei der Behandlung von COVID-19 weiterentwickelt. Mit Hauptsitz in Charlottesville, Virginia, wurde Diffusion Pharmaceuticals Inc. im Jahr 2001 gegründet.
Financials
| Indicator | 31.12.2024 | 31.12.2025 |
|---|---|---|
| Bilanzsumme | 43,1 Mio. $ | 22,9 Mio. $ |
| Gewinn | −16,3 Mio. $ | −27 Mio. $ |
| Umsatz | 0,00 $ | 0,00 $ |
| Eigenkapital | 39,2 Mio. $ | 18,2 Mio. $ |
| EK-Quote | 91 % | 79,6 % |
| EK-Rendite | −41,6 % | −148 % |
| Steuern | 0,00 $ | 0,00 $ |
| Kassenbestand | 8.999.496 $ | 8.235.469 $ |
| Forderungen | 0,00 $ | 0,00 $ |
| Verbindlichkeiten | 3.879.282 $ | 4.656.117 $ |
Balance sheet
| Position | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bilanzsumme | 19.917.848 | 17.484.384 | 26.145.815 | 18.201.992 | 24.110.523 | 27.729.551 | 37.839.151 | 22.635.052 | 43.081.610 | 22.879.018 |
| Summe Umlaufvermögen | 12.175.225 | 1.603.696 | 9.666.414 | 8.914.231 | 14.649.813 | 18.776.420 | 37.823.573 | 22.635.052 | 43.081.610 | 22.879.018 |
| Zahlungsmittel und Zahlungsmitteläquivalente | 12.006.075 | 1.552.852 | 8.896.468 | 7.991.172 | 14.177.349 | 18.515.595 | 37.313.558 | 10.113.706 | 8.999.496 | 8.235.469 |
| Kurzfristige Investitionen | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.408.940 | 29.922.523 | 12.628.970 |
| Inventar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nettoforderungen | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sonstige kurzfristige Vermögenswerte | 169.150 | 50.844 | 769.946 | 923.059 | 472.464 | 260.825 | 510.015 | 112.406 | 4.159.591 | 2.014.579 |
| Summe der langfristigen Vermögenswerte | 7.742.623 | 15.880.688 | 16.479.401 | 9.287.761 | 9.460.710 | 8.953.131 | 15.578 | 0 | 0 | 0 |
| Langfristige Investitionen | 250.000 | -3.279.363 | -2.223.678 | -1.786.389 | -2.119.274.000 | -443.893 | 0 | 0 | 0 | 0 |
| Sachanlagen Netz | 57.995 | 79.755 | 460.652 | 350.281 | 499.409 | 298.360 | 0 | 0 | 0 | 0 |
| Immaterielle Vermögenswerte | 6.449.628 | 8.639.000 | 8.639.000 | 8.639.000 | 8.639.000 | 8.639.000 | 0 | 0 | 0 | 0 |
| Firmenwert | 985.000 | 6.929.258 | 6.929.258 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Übrige langfristige Vermögenswerte | 250.000 | -3.046.688 | -1.773.187 | 298.480 | 322.301 | 15.771 | 15.578 | 0 | 0 | 0 |
| Summe Verbindlichkeiten und Eigenkapital | 19.917.848 | 17.484.384 | 26.145.815 | 18.201.992 | 24.110.523 | 27.729.551 | 37.839.151 | 22.635.052 | 43.081.610 | 22.879.018 |
| Total Verbindlichkeiten | 3.478.328 | 8.299.700 | 4.915.871 | 2.590.433 | 3.976.261 | 2.915.369 | 2.927.684 | 2.417.336 | 3.879.282 | 4.656.117 |
| Total kurzfristige Verbindlichkeiten | 1.203.802 | 4.438.422 | 2.690.807 | 804.044 | 1.721.421 | 2.435.783 | 2.927.684 | 2.417.336 | 1.511.440 | 4.656.117 |
| Rechnungsabgrenzungsposten | 0 | 722.932 | 1.598.011 | 0 | 288.424 | 1.741.106 | 0 | 0 | 0 | 0 |
| Verbindlichkeiten aus Lieferungen und Leistungen | 36.110 | 1.684.158 | 511.956 | 198.818 | 1.251.412 | 545.844 | 947.495 | 1.127.782 | 1.511.440 | 1.454.118 |
| Kurzfristige Schulden | 0 | 1.880.000 | 550.000 | 0 | 111.477 | 113.469 | 0 | 0 | 0 | 0 |
| Übrige kurzfristige Verbindlichkeiten | 1.070.048 | 874.264 | 1.628.851 | 605.226 | 70.108 | 1.776.470 | 1.980.189 | 0 | 0 | 3.201.999 |
| Total langfristige Verbindlichkeiten | 2.274.526 | 3.861.278 | 2.225.064 | 1.786.389 | 2.254.840 | 479.586 | 0 | 1.289.554 | 2.367.842 | 0 |
| Langfristige Schulden | 0 | 550.000 | 0 | 0 | 135.566 | 35.693 | 0 | 0 | 0 | 0 |
| Passive Rechnungsabgrenzungsposten Langfristig | 0 | 0 | 0 | 0 | -2.119.274.000 | -443.893 | 0 | 0 | 0 | 0 |
| Latente Steuerschulden nicht kurzfristig | 2.274.526 | 3.279.363 | 2.223.678 | 1.786.389 | 2.119.274 | 443.893 | 0 | 0 | 0 | 0 |
| Übrige langfristige Verbindlichkeiten | 0 | 3.311.278 | 2.225.064 | 0 | 2.119.274.000 | 443.893 | 0 | 0 | 2.367.842 | 0 |
| Sonstige Verbindlichkeiten | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.289.554 | 0 | 0 |
| Eigenkapital gesamt | 16.439.520 | 9.184.684 | 21.229.944 | 15.611.559 | 20.134.262 | 24.814.182 | 34.911.467 | 20.217.716 | 39.202.328 | 18.222.901 |
| Stammaktie | 18.615 | 10.346 | 14.520 | 3.377 | 33.481 | 64.016 | 101.914 | 2.040 | 8.702 | 9.252 |
| Vorzugsaktien | 0 | 0 | 26.145.815 | 18.201.992 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gewinnrücklagen | -99.111.049 | -60.189.237 | -61.554.889 | -79.924.699 | -91.724.078 | -105.909.384 | -130.005.111 | -145.596.539 | -70.731.484 | -97.697.851 |
| Kumulierter sonstiger Ergebnisverlust | 0 | 0 | -26.145.815 | -417.189 | 0 | 0 | 0 | -35.375 | 56.197 | 5.816 |
| Sonstiges Eigenkapital insgesamt | 115.531.954 | 69.373.921 | 56.639.018 | 95.532.881 | 111.824.859 | 130.659.550 | 164.814.664 | 165.847.590 | 109.868.913 | 115.905.684 |
Companies at this address & nearby
Which companies share the address, street or postal code of Diffusion Pharmaceuticals Inc.? Registered office clusters often reveal corporate networks, shell structures and shared back offices — sorted by share capital.
Same postal code (124)
22902 Charlottesville
- 107 5th Street LLC
P.O. Box 1467, 22902 Charlottesville · S8467963
- 1255 East Independence LLC
Po Box 2998, 22902 Charlottesville · LC001676028
- 250 West Main Street LLC
416 East Main Street, 22902 Charlottesville · S1802869
- 321-323 East Main Street LLC
455 2ND Street SE, 5TH Floor, 22902 Charlottesville · S1285925
- 853 West Main LLC
801 W Main ST STE 201, 22902 Charlottesville
- Abington Place LLC
112 West Main Street, 22902 Charlottesville · S3832724
- Albemarle Storage LLC
1501 Avon Street Extended, 22902 Charlottesville · S1444639
- Anchor 101 Greenfield MOB Owner LLC
402 Park Street, 22902 Charlottesville · _c5078764492685312
230 companies are registered in Charlottesville in total.
FAQ — Diffusion Pharmaceuticals Inc.
- What is the LEI of Diffusion Pharmaceuticals Inc.?
- The Legal Entity Identifier (LEI) of Diffusion Pharmaceuticals Inc. is 549300I3DV7F8OXPNA12.
- Where is Diffusion Pharmaceuticals Inc. registered?
- Diffusion Pharmaceuticals Inc. has its registered address in Charlottesville, Yhdysvallat.
- Is the register extract of Diffusion Pharmaceuticals Inc. free of charge?
- Yes. Eulerpool provides all company register data — including the complete record of Diffusion Pharmaceuticals Inc. — completely free of charge, with no login required.
Official registry record
Täydellinen virallinen rekisteriote – jokainen LEI-/yritysrekisterin kenttä, ilmainen, sisäänkirjautumista ei vaadita.
| legal_name | Diffusion Pharmaceuticals Inc. |
|---|---|
| legal_city | Charlottesville |
| legal_jurisdiction | US |
| lei | 549300I3DV7F8OXPNA12 |
| legal_first_address_line | 300 East Main Street |
| legal_postal_code | 22902 |
| headquarters_city | Charlottesville |
| headquarters_postal_code | 22902 |
| registration_status | active |
| entity_legal_form_code | Inc. |
| registry_id | 4826839659839488 |
| source | registry |